SHUKRA PHARMACEUTICALS L Share Price

₹ 79.90

+₹5.03 (6.72%)
1D
Last updated 02 Nov, 2026, 15:57 IST
NSE: SHUKRAPHAR
|
Pharmaceuticals

SHUKRA PHARMACEUTICALS L Share Price Today

As of 3 Nov 2026, SHUKRA PHARMACEUTICALS L share price is ₹79.90. The stock opened at ₹75.35, compared to its previous close of ₹74.87. During today's trading session, SHUKRA PHARMACEUTICALS L share price moved in the range of ₹74.53 to ₹82.28, with an average price of ₹78.41 for the day. Looking at its last 52-week, the stock has touched a low of ₹40.06 and a high of ₹82.28. On the performance front, SHUKRA PHARMACEUTICALS L share price has increased by 92.90% over the last six months and is up 92.90% on a year-on-year basis.

Share price over the last 1 day rose from 75.90 to 79.90, ranging between 74.53 and 81.85.
₹74.53
6.72% up today
₹82.28
1D LOW
1D HIGH

SHUKRA PHARMACEUTICALS L Stock Insights

Latest Earning
Op Profit TrendUp by 4681.58% QoQ
Latest Earning
Net Profit TrendUp by 853.49% QoQ
Latest Earning
Revenue TrendUp by 230.95% QoQ
Stock Performance
OutperformingBeat Nifty by 18.67 % in last 1 month
Shareholding Pattern
DIIDII increased stake by 88.04%
Shareholding Pattern
FIIFII increased stake by 12697.06%
SHUKRA PHARMACEUTICALS L stock performance
Open₹75.35
High₹82.28
Low₹74.53
Prev. close₹74.87
SHUKRA PHARMACEUTICALS L trading activity
Volume1,23,85,999
Average traded price₹79.01
Last traded time03:57:47 02 Nov
Last traded quantity202
Circuit
L
H
₹63.92
₹95.88
52-week
L
H
₹40.06
₹82.28
Mkt Cap Cr
3,316.71
P/E
97.34
P/B
32.85
ROA
28.93%
ROE
24.55%
ROCE
31.5%
Quick Ratio
3.03
EV/EBITDA
65.5

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Shukra Pharma. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Shukra Pharma. appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Shukra Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SHUKRA PHARMACEUTICALS L Company Background

ISIN
INE551C01044
Sector Market Cap
₹ 3,316.71 Cr

Shukra Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical products globally and domestically. The Company’s product portfolio consists of tablet and capsules (general) solid oral dosage form and small volume parenteral- liquid injection vial and ampules. The Company’s products include Losartan Potassium Tablets USP 50 mg, Glimepiride Tablets USP 2 mg, Pantoprazole Tablets USP 40 mg, Methocarbamol Tablets USP 500 mg, Omeprazole Capsule IP 20 mg, Amlodipine besylate Tablets USP 5 mg, Ranitidine Tablets USP 150 mg, Ranitidine Tablets USP 300 mg, Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Atorvastatin Tablets USP 10mg, Sildenafil citrate Tablets BP 100 mg, Diclofenac Sodium Tablets BP 50 mg, Mebendazole Tablets USP 100 mg, Paracetamol Tablets BP 500 mg, Artemether 80 mg and Lumefantrine 480 mg Tablets, Clotrimazole Vaginal Tablets 100 mg and others.

SHUKRA PHARMACEUTICALS L Financial Highlights

  • Revenue: SHUKRA PHARMACEUTICALS L reported revenue of ₹61.31 crore in FY26 vs ₹36.80 crore in FY25. It showed an increase of 66.60% on a yearly basis.
  • Operating Profit: SHUKRA PHARMACEUTICALS L reported an operating profit of ₹28.79 crore in FY26 vs ₹13.34 crore in FY25. It showed an increase of 115.82% on a year-on-year basis.
  • Net Profit: SHUKRA PHARMACEUTICALS L reported a net profit of ₹22.06 crore in FY26 vs ₹9.58 crore in FY25. It showed an increase of 130.27% on a yearly basis.

SHUKRA PHARMACEUTICALS L Quarterly Result Highlights

  • SHUKRA PHARMACEUTICALS L reported revenue of ₹24.06 crore in Jun 2026, compared with ₹7.27 crore in Mar 2026, representing an increase of 230.95% on a quarter-on-quarter (QoQ) basis.
  • SHUKRA PHARMACEUTICALS L reported an operating profit of ₹18.17 crore in Jun 2026, compared with ₹0.38 crore in Mar 2026, representing an increase of 4,681.58% on a quarter-on-quarter (QoQ) basis.
  • SHUKRA PHARMACEUTICALS L reported a profit of ₹12.96 crore in Jun 2026, compared with ₹1.72 crore in Mar 2026, reflecting an increase of 853.49% on a QoQ basis.
  • The earnings per share (EPS) of SHUKRA PHARMACEUTICALS L stood at ₹0.50 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
51.15%
FII
0.44%
Other DII
0.21%
Retail and other
48.20%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.00%
Jun 20260.00%
Aug 20260.00%
Sep 20260.44%

SHUKRA PHARMACEUTICALS L Investment Returns

1 day
+6.72%
1 week
+18.44%
1 month
+29.29%
1 year
+92.90%
3 years
+92.90%
5 years
+92.90%

SHUKRA PHARMACEUTICALS L Share Price History

SHUKRA PHARMACEUTICALS L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹75.35 / ₹79.90
+6.72%
30 Oct 26
₹75.84 / ₹74.87
-0.25%
29 Oct 26
₹72.23 / ₹75.06
+4.37%
28 Oct 26
₹72.10 / ₹71.92
+0.53%
Show more

SHUKRA PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹56.71₹32.59
Other Income₹4.58₹4.21
Total Revenue₹61.29₹36.79
Total Expenses₹32.52₹23.46
Profit Before Tax₹28.77₹13.34
Tax₹6.73₹3.76
Profit After Tax₹22.05₹9.58
EPS - Basic₹0.50₹0.22
EPS - Diluted₹0.50₹0.22

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹28.77₹13.34
Income before WC changes₹31.59₹15.46
Change in Assets-₹24.52-₹7.06
Change in Liabilities-₹2.30₹3.28
Change in WC-₹26.82-₹3.78
Cash flow from Operations₹3.15₹7.92
Cash flow from Investing-₹14.18-₹1.26
Cash flow from Financing₹4.83-₹4.52
Total Cash Flow-₹6.20₹2.14
Cash (Start of the year)₹12.12₹9.98
Cash (End of the year)₹5.92₹12.12

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹33.66₹21.34
Current Assets₹83.75₹65.43
Total Assets₹117.41₹86.77
Current Liabilities₹23.08₹17.29
Net Current Asset₹60.67₹48.14
Non-Current Liabilities₹4.50₹6.65
Equity Capital₹89.83₹62.84
Total Equity & Liabilities₹117.41₹86.77

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹56.71₹32.59₹74.57₹58.83
Other Income₹4.58₹4.21₹2.82₹1.20
Total Revenue₹61.29₹36.79₹77.39₹60.03
Total Expenses₹32.52₹23.46₹57.50₹55.59
Profit Before Tax₹28.77₹13.34₹19.88₹4.44
Tax₹6.73₹3.76₹1.35₹0.04
Profit After Tax₹22.05₹9.58₹18.54₹4.41
EPS - Basic₹0.50₹0.22₹16.93₹26.21
EPS - Diluted₹0.50₹0.22₹16.93₹26.21

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹28.77₹13.34₹19.88₹4.44
Income before WC changes₹31.59₹15.46₹21.43₹6.04
Change in Assets-₹24.52-₹7.06₹2.85-₹33.27
Change in Liabilities-₹2.30₹3.28-₹28.85₹30.64
Change in WC-₹26.82-₹3.78-₹26.01-₹2.62
Cash flow from Operations₹3.15₹7.92-₹5.20₹3.17
Cash flow from Investing-₹14.18-₹1.26-₹1.20-₹4.43
Cash flow from Financing₹4.83-₹4.52₹12.41₹4.94
Total Cash Flow-₹6.20₹2.14₹6.01₹3.68
Cash (Start of the year)₹12.12₹9.98₹3.97₹0.29
Cash (End of the year)₹5.92₹12.12₹9.98₹3.97

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹33.66₹21.34₹21.60₹21.89
Current Assets₹83.75₹65.43₹56.23₹53.07
Total Assets₹117.41₹86.77₹77.84₹74.97
Current Liabilities₹23.08₹17.29₹14.15₹42.51
Net Current Asset₹60.67₹48.14₹42.08₹10.57
Non-Current Liabilities₹4.50₹6.65₹6.04₹7.16
Equity Capital₹89.83₹62.84₹57.64₹25.30
Total Equity & Liabilities₹117.41₹86.77₹77.84₹74.97
* All values are in INR Crore
SHUKRA PHARMACEUTICALS L market depth
Bid quantityBid priceAsk priceAsk quantity
2572579.900
0000
0000
0000
0000
Total bid quantity25,725
Total ask quantity0
SHUKRA PHARMACEUTICALS L technical summary
Bearish indicators4
Neutral indicators2
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
78.6
Bullish
ATR (14)
5.44
Neutral
STOCH(9,6)
92.62
Bearish
STOCH RSI (14)
99.73
Bearish
ADX(9)
35.21
Bearish
UO(9)
58.45
Neutral
ROC(12)
19.32
Bullish
WillR(14)
-7.38
Bearish
Period
Simple value
Exponential vaue
5D
72.17
72.44
10D
69.37
70.33
20D
68.38
67.66
50D
58.27
72.15
100D
57.32
0
Volume trend — traded volume by day
2 Nov1Cr
30 Oct92L
29 Oct2Cr
28 Oct1Cr
27 Oct1Cr
Average1Cr

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SHUKRA PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

SHUKRA PHARMACEUTICALS L Returns Calculator

Ex-date: 21 Sep 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

SHUKRA PHARMACEUTICALS L Share Price FAQs

Please be aware that SHUKRA PHARMACEUTICALS L stock prices are subject to continuous fluctuations due to various factors.